Data / Form D filings / GelMEDIX, Inc.
GelMEDIX, Inc.: Form D filings
GelMEDIX, Inc., a biotechnology company in Cambridge, MA, filed 8 Form D notices with the SEC between 2020 and 2026. The latest, on April 30, 2026, reports $747,000 sold of a $2.5 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 238 MAIN STREET, FIFTH FLOOR, Cambridge, MA, 02142
- Phone
- (941) 228-8711
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1815624
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | Amendment | $2,500,000 | $747,000 | $1,753,000 | 5 | Oct 1, 2025 | sec.gov |
| Jan 8, 2026 | Amendment | $542,000 | $542,000 | 5 | Oct 1, 2025 | sec.gov | |
| Oct 14, 2025 | New notice | $397,000 | $397,000 | 2 | Oct 1, 2025 | sec.gov | |
| Feb 4, 2025 | New notice | $4,000,000 | $1,000,000 | $3,000,000 | 2 | Jan 24, 2025 | sec.gov |
| Mar 26, 2024 | New notice | $3,500,000 | $1,893,339 | $1,606,661 | 17 | Mar 11, 2024 | sec.gov |
| Aug 10, 2022 | Amendment | $8,035,000 | $6,440,000 | $1,595,000 | 4 | Jun 4, 2020 | sec.gov |
| Apr 29, 2021 | Amendment | $5,000,000 | $2,600,000 | $2,400,000 | 4 | Jun 4, 2020 | sec.gov |
| Jun 19, 2020 | New notice | $1,000,000 | $250,000 | $750,000 | 1 | Jun 4, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Max Cotler | Executive Officer, Director | |
| Nasim Annabi | Director | |
| Reza Dana | Director | |
| Michael Cima | Director | |
| Parinaz Motamedy | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Apr 27, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GelMEDIX, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.